Related Experiment Video
Updated: Apr 11, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.8K
Caution with new oral hepatitis C drugs
Vicente Soriano1, Isabella Esposito1
1La Paz University Hospital & IdiPAZ, Madrid, Spain.
AIDS Reviews
|June 3, 2015
Summary
Direct-acting antiviral therapies offer a revolution in hepatitis C treatment, achieving high cure rates for most patients. This includes individuals coinfected with HIV, who experience similar successful outcomes.
Area of Science:
- Hepatology
- Infectious Diseases
- Virology
Background:
- Hepatitis C virus (HCV) infection affects approximately 20% of individuals with human immunodeficiency virus (HIV) globally.
- Recent advancements in antiviral therapies have transformed HCV management.
- The efficacy of new treatments in coinfected populations requires specific evaluation.
Discussion:
- DAA combinations demonstrate over 90% cure rates in HIV/HCV-coinfected patients, comparable to HCV mono-infected individuals.
- The efficacy of modern HCV therapies is not compromised by the presence of HIV.
- This parity in treatment outcomes supports a unified approach to HCV management.
Key Insights:
- HIV/HCV-coinfected patients experience successful HCV eradication with DAAs at rates exceeding 90%.
- Treatment outcomes for HCV are similar regardless of HIV co-infection status.
- Current therapeutic guidelines now reflect this equivalence in treatment efficacy.
Outlook:
- The successful management of HCV in co-infected populations simplifies clinical protocols.
- Continued research may further optimize DAA regimens for diverse patient groups.
- Eliminating HCV as a public health threat is increasingly feasible, even in complex co-infected scenarios.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.8K
09:29Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
31.0K
Related Concept Videos
01:25Hepatitis
55
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
55
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
609
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
609
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
351
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
351
01:30Inhibitors of Viral Protein Synthesis
34
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
34
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
347
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
347
01:16Hepatic Drug Excretion: Influencing Factors
765
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
765